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Blood pressure change across 
pregnancy in white British and 
pakistani women: analysis of data 
from the Born in Bradford cohort
Diane farrar  1, Gillian Santorelli  1, Debbie A. Lawlor2,3,4, Derek Tuffnell5, 
trevor A. Sheldon6, Jane West  1 & corrie Macdonald-Wallis7
the incidence of gestational hypertension (GH) and pre-eclampsia (pe) is increasing. Use of blood 
pressure (Bp) change patterns may improve early detection of Bp abnormalities. We used Linear 
spline random-effects models to estimate BP patterns across pregnancy for white British and 
Pakistani women. Pakistani women compared to white British women had lower BP during the first 
two trimesters of pregnancy, irrespective of the development of GH or pe or presence of a risk factor. 
pakistani compared to white British women with GH and pe showed steeper Bp increases towards the 
end of pregnancy. pakistani women were half as likely to develop GH, but as likely to develop pe than 
white British women. To conclude; BP trajectories differ by ethnicity. Because GH developed evenly 
from 20 weeks gestation, and PE occurred more commonly after 36 weeks in both ethnic groups, the 
lower Bp up to the third trimester in pakistani women resulted in a lower GH rate, whereas pe rates, 
influenced by the steep third trimester BP increase were similar. Criteria for diagnosing GH and PE may 
benefit from considering ethnic differences in BP change across pregnancy.
Ten percent of pregnant women will develop gestational hypertension (GH) or pre-eclampsia (PE)1–4. The inci-
dence of these conditions is increasing and influenced by population characteristics, in particular the rise in over-
weight and obesity5,6. GH and PE are major causes of maternal and infant perinatal morbidity and mortality7–9. 
There is also growing evidence that the longer-term cardiovascular health of the mother and offspring exposed to 
GH or PE may be adversely affected10,11. Consequently the burden to the individual and to health services is grow-
ing12–14. Early detection and treatment of pregnancy hypertension can reduce risks15–17, but this early detection is 
somewhat hampered by the diagnosis of GH or PE being defined as hypertension after 20 weeks of gestation (i.e. 
after the nadir of early pregnancy decline in BP reported in many previous studies)18–20.
Hypertensive disorders of pregnancy (HDP) which includes GH and PE, represents a spectrum of disorders, 
all of which are characterised by high diastolic (DBP) or systolic (SBP) blood pressure (BP)21. Elevated BP after 
20 weeks in women without a history of hypertension is defined as GH; when it occurs with clinically significant 
levels of proteinuria it is PE21,22. The offspring of women who develop PE, more so than those developing GH, are 
at greater risk of adverse outcomes including preterm birth and small for gestational age23. Normal pregnancy is 
characterised by decreasing levels of BP from conception to 20 weeks then a slight and steady increase thereafter 
to term20. Elevated BP after 20 weeks in all cases of HDP can be reached by different patterns of gestational BP 
change, including higher than average levels from conception, a smaller decline in BP in early pregnancy and/or 
a more rapid or pronounced rise following this early pregnancy decline. Whether different patterns of reaching 
the criteria for GH and PE are helpful in predicting more adverse outcomes, or what risk factors influence them 
is unclear and this information may be important when considering diagnostic thresholds and treatment of GH 
and PE in different ethnic groups.
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We have shown previously that in white European women without GH or PE, mean BP at the start of preg-
nancy, the rate of decline in early pregnancy and the steepness of the increase in late pregnancy, differs by 
established risk factors (age, parity, BMI, multiple pregnancy) in the same direction that those risk factors are 
associated with HDP18,24. We have further shown that early BP change can be used to predict which women are 
likely to experience a HDP, and proposed gestational BP centile charts for use in white European women25,26.
South Asians, in comparison to white Europeans, have higher levels of adiposity for a given body mass from 
birth, and are at increased risk of insulin resistance, diabetes and coronary heart disease27–30. In pregnancy this 
is reflected in higher rates of gestational diabetes and mean levels of fasting and post-load glucose29,31. Greater 
adiposity and gestational diabetes are both associated with an increased risk of a HDP23,32,33, therefore we might 
expect HDP to be more common in south Asian women. However, the small number of studies that have com-
pared the incidence of HDP between south Asian and white Europeans have found either a lower or similar 
incidence34–37. To our knowledge few previous studies have examined ethnic differences in SBP and DBP change 
across pregnancy. Those that have include few women from ethnic groups other than white European38,39.
The aims of this study were to explore whether: (i) patterns of BP change in pregnancy differed between white 
British and Pakistani women; (ii) any differences in BP change between these two ethnic groups were related to 
differences in GH and PE incidence and whether (iii) established risk factors (maternal age, BMI and parity) for 
GH and PE differed between the ethnic groups in how they relate to BP trajectories and GH and PE incidence.
By addressing these aims we hope to better understand the mechanisms that might lead to ethnic differences 
in HDP incidence and to provide the foundations for exploring whether different thresholds for diagnosing GH 
and PE between these different ethnic groups would improve their detection, management and outcomes.
Methods
participants. Our analyses were undertaken in two ethnic groups – white British and Pakistani women, 
because these represent the largest ethnic groups in our cohort study. Data from women participating in the 
Born in Bradford (BiB) cohort were used. BiB is a prospective birth cohort study including 12,450 women who 
booked to deliver at the Bradford Royal Infirmary, Bradford, UK, between 2007 and 2011. The cohort is broadly 
representative of the obstetric population in Bradford and includes equal numbers of Pakistani and white British 
women. The study methods have been described in full elsewhere40. At recruitment, participants gave informed 
written consent, height and weight was measured, a questionnaire was administered by trained research assis-
tants and information was abstracted from medical records, informed written consent was also given by partic-
ipants for the future abstraction of information from medical records. Interviews were conducted in English or 
in south Asian languages (including Urdu and Mirpuri). Research Ethics Committee approval was obtained (07/
H1302/112), all research was performed in accordance with relevant guidelines and regulations. Women were 
excluded if they did not complete a baseline questionnaire, had one or less BP measurement recorded antenatally 
or did not have their birth outcomes recorded. Following further exclusions (women with pre-existing hyperten-
sion, multiple pregnancies or ‘other’ ethnicities (than white British or Pakistani)), 8212 women were included in 
these analyses. Figure 1 shows the full inclusion and exclusion criteria of women from BiB for this study.
outcomes. All BP and proteinuria measurements that were recorded as part of routine antenatal care were 
abstracted from each participant’s medical records (i.e. each woman would have several repeat measurements of 
SBP, DBP and proteinuria).
These repeat measurements were conducted by midwives, doctors or health care assistants working in the 
community or hospital clinics, who were trained to measure BP in the seated position using the appropriate cuff 
size, diastolic BP (DBP) was measured using Korotkoff phase V. Most measurements were scheduled according 
Figure 1. Study flow chart.
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to UK clinical guideline recommendations (at 10, 16, 28, 34, 36, 38, 41 weeks gestation and additionally at 25, 
31 and 40 weeks gestation for women during their first pregnancy)41. Women who were deemed to require addi-
tional monitoring by their clinical team or who self-referred for various reasons (for example abdominal pain 
or reduced fetal movements) had measurements recorded at additional times. A variety of devices were used to 
measure BP and proteinuria, all devices were calibrated according to standard UK health service practice21. The 
gestational age on the date of each measurement was derived from the infant’s gestational age at birth and date of 
measurement, gestational age at birth was derived from the 10 week ultrasound scan and date of birth.
The extraction of BP and proteinuria measurements from paper medical records was undertaken by four 
trained research assistants. Accuracy of abstractions was checked on 5% of records for all abstracted data; all 
error rates were less than 1%. The BP and proteinuria repeat measurements were used to derive gestational BP 
change trajectories across pregnancy and also to define GH and PE in a systematic way for all participants. GH 
was defined as new-onset hypertension after 20 weeks gestation; DBP equal to or exceeding 90 mmHg and/or 
SBP equal to or exceeding 140 mmHg on at least two separate occasions. PE was defined as for GH, but also with 
concurrent (with the elevated blood pressure) clinically significant proteinuria; greater or equal to 1 ‘+’ on the 
reagent strip reading (the equivalent of ~30 mg/mmol [0.3 mg/mg] on spot urine protein/creatinine ratio)21,22.
ethnicity, HDp risk factors and other measurements. The woman’s ethnicity, age, education, parity and 
smoking during pregnancy were obtained from interviewer administered questionnaires at recruitment. Ethnicity 
was categorised as white British and Pakistani according to UK Office of National Statistics criteria42. Education was 
equivalized to UK standard attainments and participants were included in one of five mutually exclusive categories 
(<5 GCSE equivalent, +5 GCSE equivalent, A level equivalent, higher, other)29. Family history of diabetes and 
hypertension was abstracted from antenatal clinical paper records as described above for the repeat BP and pro-
teinuria measures. Maternal weight as recorded at the first antenatal clinic visit, glucose levels (at the 26–28 week 
gestation oral glucose tolerance test) and infant sex43 were obtained from hospital electronic records. Gestational 
diabetes was defined according to modified World Health Organization (WHO) criteria operating at the time of 
recruitment (either fasting glucose ≥6·1 mmol/L, or 2 h post-load glucose ≥7·8 mmol/L)29,44.
Body mass index (BMI kg/m2) was calculated using height from the recruitment assessment and the first 
antenatal clinic visit weight, which was generally before 12 weeks gestation, as that would be little influenced by 
pregnancy or fetal size in comparison to the measure at recruitment (around 28 weeks). BMI was categorised 
according to WHO definitions of underweight or normal (≤24.9 kg/m2; there being too few women to categorize 
underweight separately), overweight (≥25.0–29.9 kg/m2) and obese (≥30.0 kg/m2)45. Smoking during pregnancy 
which was self-reported and categorized as yes or no.
Statistical analysis. Linear spline random-effects models were used to derive SBP and DBP change trajectories 
across gestation, as previously described18,24. Multilevel modelling (using antenatal visit as level 1 and woman as level 
2) was conducted to account for multiple antenatal measurements and clustering (non-independence) of these within 
each woman. The median, interquartile range, and full range of the number of BP measurements per woman were 10, 
8–14 and 1–142 respectively. In order to prevent the small number of women with many repeat measurements overly 
influencing results we split gestation into two week periods and for any woman who had more than one measure in 
any of these two-week periods, one measurement was selected at random to remain in the analyses. This was achieved 
by creating a random number for each record using the invnorm(uniform)) command in Stata, sorting data by par-
ticipant identifier, gestation period and random number, then choosing the first record within each gestation period. 
Following this, there was a median of 9 BP measurements per woman (interquartile range, 8–10 and full range 2–16).
The best fitting model was derived using fractional polynomials; we examined these in the whole cohort 
and for the two ethnic groups, with the appearance of the average cohort trajectory from this modelling used to 
explore potential knot points. Knot points are the gestational ages at which a change in the direction or magnitude 
of BP trajectory slopes occurs. We examined the five highest log-likelihoods for SBP and DBP models separately, 
in the whole cohort and also separately for white British and Pakistani women. Our aim was to identify knot 
points that were a good reflection (fit) of the observed data and if possible have similar knot points for both SBP 
and DBP and for both ethnic groups in order to aid comparisons. We set eight weeks gestation as the baseline 
(intercept) as there were too few measurements before that time to produce meaningful results. The modelling 
created five measurements of SBP and DBP change for each woman: baseline level at 8 weeks (intercept) and 
change between 8 and 24, 24 and 30, 30 and 36 weeks and 36 weeks to delivery.
Women with PE have a high risk of preterm delivery, particularly if maternal BP rises rapidly, and earlier deliv-
ery may lead to fewer measurements contributing to the models and thus a lower influence from pregnancies with 
a steeper increase in BP, so underestimating the slope. In order to adust for this, we combined the random-effects 
spline models for BP change with length of gestation to produce a joint model18. Individual trajectories and 
trajectories by categorical covariates were obtained from random-intercept and -slope models, which provide a 
measure of each individual’s deviation from the whole cohort mean BP at 8-weeks and from the average slope in 
each period of gestation. The following covariates were explored in these models: HDP (normotensive (reference 
group), GH, PE); age (<25 (reference) 25–29, 30–35, >35); BMI (underweight/normal (reference), overweight, 
obese); ethnicity (white British (reference), Pakistani); parity (nulliparous (reference), multiparous); smoking 
in pregnancy (no (reference), yes); gestational diabetes (no (reference), yes); education (<5 GCSE equivalent 
(reference), 5+ GCSE equivalent, A level equivalent, higher, other) and offspring sex (male (reference), female).
The associations between BP changes and time to delivery were derived from the random effects for BP out-
comes and the residual error from the length of gestation. Our initial model (model 1) adjusted for all covariates 
(described above). In model 2, we additionally adjusted each slope (mean change in BP per gestational week) 
for the mean BP at 8 weeks, and each proceeding slope(s), so that results were not confounded by the initial BP 
measure and earlier slope(s) which correlate with subsequent slopes18,24.
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ethics approval. Ethics approval was granted by the Bradford National Health Service Research Ethics 
Committee (ref 07/H1302/112) on 10 March 2008.
Results
Table 1 shows the distribution of characteristics of all women and by ethnic group; 4345 were Pakistani and 3867 
white British. Compared to white British women, Pakistani women were older, were more likely to have attained 
a higher educational level, to be multiparous, less likely to be obese or to have smoked in pregnancy and more 
likely to have developed gestational diabetes in the current pregnancy and to have a family history of diabetes or 
hypertension.
Approximately twice as many white British than Pakistani women developed GH (11% vs 5%), whereas sim-
ilar proportions of white British and Pakistani women developed PE (3% vs 2%). Of those who developed GH 
in both ethnic groups approximately half developed it between 20 to 36 weeks of gestation and half at or after 36 
weeks, whereas most cases of PE in both groups developed at or after 36 weeks (see Table 2).
Table 3 shows the unadjusted associations between risk factors and GH and PE by ethnicity. Generally, point 
estimates tended to be closer to the null for Pakistani women than for white British women.
Figure 2a–f show the time to delivery adjusted trajectories (i.e. joint model) of SBP and DBP across pregnancy 
for Pakistani and white British women who were normotensive (see Fig. 2a,b), and who developed GH (see 
Fig. 2c,d) or PE (see Fig. 2e,f). Tables 4 and 5 show the corresponding mean differences in SBP and DBP respec-
tively at 8 weeks and the change in BP at each subsequent period. Pakistani women who remained normotensive 
started pregnancy with lower SBP (−4.00, 95% CI: −4.71 to −3.29) and DBP (−1.92, 95% CI:−2.44 to −1.40) 
and demonstrated lower BP trajectories across pregnancy compared to white British women.
All women 
N = 8,212
White British 
women N = 3,867
Pakistani women 
N = 4,345 P-valuec
Gestational age at delivery, weeksa 39 (38–40) 40 (39–40) 39 (38–40) <0.001
Hypertensive disorder of pregnancy (HDP)
No HDP 7,376 (90) 3,326 (86) 4,050 (93) <0.001
Gestational hypertension 622 (8) 428 (11) 194 (5)
Pre-eclampsia 214 (3) 113 (3) 101 (2)
Maternal age at infant birth (years)
<25 2,788 (34) 1,516 (39) 1,272 (29) <0.001
25–29 2,641 (32) 1,090 (28) 1,551 (36)
30–34 1,778 (22) 767 (20) 1,011 (23)
≥35 1,005 (12) 494 (13) 511 (12)
BMI at pregnancy booking (kg/m2)b (mean) 26.2 26.9 25.6 <0.001
   Underweight (BMI ≤ 19) 503 (6) 154 (4) 349 (8)
   Normal (BMI 19–24) 3,482 (42) 1,608 (42) 1,874 (43)
   Overweight (BMI 25–29) 2,446 (30) 1,126 (29) 1,320 (30)
   Obese (BMI > 30) 1,781 (22) 979 (25) 802 (19)
Parity:
Nulliparous 3,291 (40) 1,875 (49) 1,416 (33) <0.001
Multiparous 4,921 (60) 1,992 (52) 2,929 (67)
Smoked during pregnancy
Yes 1,452 (18) 1,302 (34) 150 (4) <0.001
Highest educational achievement
<5 GCSE equivalent 1,883 (23) 766 (20) 1,117 (26) <0.001
5+ GCSE equivalent 2,694 (33) 1,332 (35) 1,362 (31)
A-level equivalent 1,221 (15) 659 (17) 562 (13)
Higher 1,867 (23) 744 (19) 1,123 (26)
Other 547 (7) 366 (10) 181 (4)
Infant gender
Male 4,212 (51) 1,990 (52) 2,222 (51) 0.771
Female 4,000 (49) 1,877 (49) 2,123 (49)
Gestational diabetes 660 (8) 191 (5) 469 (11) <0.001
Family history of diabetes 2,045 (25) 514 (13) 1,531 (35) <0.001
Family history of hypertension 2,167 (26) 901 (23) 1,266 (29) <0.001
Pre-existing diabetes 15 (<1) 9 (<1) 6 (<1) 0.316
Table 1. Characteristics for all participants and by ethnicity. Values are n (%) unless otherwise indicated. 
aMedian and interquartile range. bBody mass index. cDifference between white British and Pakistani women 
using Wilcoxon rank sum test or chi-squared test as appropriate.
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There was no evidence of an early pregnancy decline in SBP or DBP in normotensive women for either ethnic 
group, with a very slight increase in BP in both groups across pregnancy up to 24 weeks, after which the magni-
tude of rate of change increased (see Fig. 2a,b and Tables 4 and 5).
As with normotensive Pakistani women, Pakistani women who developed GH had lower SBP (−4.93, 95% 
CI: −7.74 to −2.12) and DBP (−1.58, 95% CI: −3.60 to 0.44) at the start of pregnancy than white British women 
who developed this condition, and continued with lower levels until 36 weeks. From 36 weeks onwards, a steeper 
increase in SBP occurred than the increase demonstrated by white British women, such that by delivery Pakistani 
women with GH had similar SBP and DBP to white British women with GH (see Fig. 2c,d and Tables 4 and 5).
Pakistani women who developed PE began pregnancy with lower SBP (−2.58, 95% CI: −7.16 to 2.00) but 
similar DBP (0.48, 95% CI: −2.93 to 3.88) than white British women who developed this condition. Pakistani 
women demonstrated a steeper increase in BP from 30 weeks gestation than white British women. (see Fig. 2e,f). 
The steepness of the increase continued to term, which meant that by delivery, Pakistani women’s SBP and DBP 
were similar to those of white British women. White British women who developed PE showed a decline in BP 
from 24 weeks, their BP reached a nadir at 30 weeks, after which time both SBP and DBP increased until term. 
Pakistani women with PE did not show a similar decline in BP.
Supplementary Figures 1a to 7b show the adjusted (Model 2) average shaped SBP trajectories and 
Supplementary Figures 8a to 14b the adjusted (Model 2) average shaped DBP trajectories for Pakistani and white 
British women by HDP category and maternal risk factor. These trajectories were consistent with what we would 
expect from patterns seen with associations of each risk factor with each HDP. Supplementary Tables 1 and 2  
show the adjusted mean difference (with 95% CI) in SBP and DBP at eight weeks and change in SBP and DBP in 
each period of gestation by GH and PE for each ethnic group.
Hypertensive disorder of pregnancy
Number of weeks of gestation at 
which each hypertensive disorder of 
pregnancy developed
20–36 weeks ≥36
Gestational hypertension N (%)
White British 231 (54) 197 (46)
Pakistani 86 (44) 108 (56)
Preeclampsia N (%)
White British 15 (13) 98 (87)
Pakistani 25 (25) 76 (75)
Table 2. Total numbers developing gestational hypertension at any time in pregnancy: 428 White British and 
194 Pakistani women; Total numbers developing preeclampsia at any time in pregnancy:113 White British and 
101 Pakistani women.
Difference in means (continuous variables), Odds ratios (binary) or relative risk ratios 
(multinomial) [95% CI]
White British women Pakistani women
No HDP 
(N = 3326) 
Reference
Gestational 
hypertension 
(N = 428)
Preeclampsia 
(N = 113)
No HDP 
(N = 4050) 
Reference
Gestational 
hypertension 
(N = 194)
Preeclampsia 
(N = 101)
Risk factor
BMI (km/m2, reference <25)
   25 to 29 1 2.15 (1.61, 2.86) 2.01 (1.24, 3.26) 1 1.35 (0.93, 1.96) 1.61 (0.97, 2.66)
   30+ 1 5.59 (4.31, 7.24) 3.34 (2.10, 5.32) 1 3.56 (2.53, 5.01) 3.77 (2.34, 6.06)
Maternal age (years, reference <25)
   25 to 29 1 1.22 (0.94, 1.58) 1.01 (0.64, 1.60) 1 1.02 (0.71, 1.48) 0.73 (0.45, 1.20)
   30 to 34 1 1.30 (0.97, 1.72) 0.94 (0.55, 1.60) 1 1.08 (0.73, 1.59) 0.67 (0.39, 1.16)
   35+ 1 2.21 (1.65, 2.96) 1.14 (0.63, 2.06) 1 1.32 (0.84, 2.08) 0.92 (0.49, 1.74)
Parity (≥1 versus 0) 1 0.77 (0.63, 0.94) 0.55 (0.38, 0.81) 1 0.54 (0.40, 0.72) 0.40 (0.27, 0.59)
Gestational diabetes (Yes vs No) 1 1.48 (0.98, 2.22) 1.14 (0.49, 2.63) 1 1.12 (0.72, 1.75) 1.02 (0.54, 1.91)
Maternal education (reference 5 GCSE)
<5 GCSE 1 0.88 (0.65, 1.20) 1.09 (0.66, 1.80) 1 0.96 (0.66, 1.40) 0.76 (0.46, 1.28)
A level 1 1.37 (1.02, 1.83) 0.76 (0.42, 1.39) 1 0.83 (0.51, 1.36) 0.56 (0.27, 1.17)
Degree 1 1.45 (1.10, 1.92) 1.09 (0.66, 1.83) 1 0.93 (0.64, 1.37) 0.79 (0.47, 1.32)
Other 1 1.39 (0.97, 1.98) 0.64 (0.28, 1.44) 1 1.21 (0.61, 2.40) 1.00 (0.39, 2.58)
Smoking in pregnancy (Yes vs No) 1 0.55 (0.44, 0.70) 0.63 (0.41, 0.97) 1 0.72 (0.29, 1.78) 0.55 (0.13, 2.26)
Infant gender (Female vs Male) 1 0.88 (0.72, 1.07) 0.77 (0.52, 1.12) 1 0.86 (0.65, 1.16) 1.20 (0.81, 1.78)
Table 3. Unadjusted associations of risk factors with hypertensive disorders of pregnancy.
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Table 6 shows the associations of BP at eight weeks and changes in BP with time to delivery. SBP and DBP at 
8 weeks gestation and BP change in any period of pregnancy was not associated with gestational length in either 
ethnic group, with the exception of SBP, but not DBP change between 8 and 24 weeks which was weakly associ-
ated with a reduction in gestational length for white British women only.
Supplementary Table 3 shows similar predicted lengths of gestation at 2 SDs above and below the average SBP 
and DBP at 8 weeks and changes in SBP and DBP in each period of gestation for Pakistani and white British women.
Discussion
We found that Pakistani women start pregnancy with lower SBP and DBP than white British women. This is 
true for women who remain normotensive throughout their pregnancies and for those who go on to develop 
GH or PE. Generally, normotensive Pakistani and white British women, show gradual increases in BP until 36 
weeks when SBP and DBP for both ethnic groups increases more steeply until term. Compared with white British 
women, Pakistani women who developed either GH or PE had a steeper rise in BP in the third trimester and this 
difference in BP trajectories influenced the comparison of HDP between the two groups. GH was more common 
in white British women due to: (a) the combination of the same diagnostic criteria being used across ethnicities, 
Figure 2. (a,b) Predicted trajectories of systolic blood and diastolic pressure across pregnancy for Pakistani 
and white British normotensive women. (c,d) Predicted trajectories of systolic and diastolic blood pressure 
across pregnancy for Pakistani and white British women with gestational hypertension. (e,f) Predicted 
trajectories of systolic and diastolic blood pressure across pregnancy for Pakistani and white British women 
with pre-eclampsia. Footnote to (a to f). − or + Denotes where the mean difference in average BP change 
in the associated time period between White British and Pakistani women is significantly smaller or larger 
respectively.
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(b) Pakistani women having lower BP levels until the final trimester of pregnancy, and (c) women in both ethnic 
groups who developed GH doing so evenly between 20–36 and after 36 weeks gestation. By contrast, the propor-
tion with PE was similar in both ethnic groups, because in both groups those developing PE were much more 
likely to do so after 36 weeks, which meant that the steeper third trimester rise in BP in Pakistani women had a 
greater impact on their PE rate than their GH rate.
A number of previous studies have reported ethnic differences in the occurrence of GH and PE and the associ-
ation of risk factors with GH and PE and adverse outcomes for different ethnic groups36,46,47 and one study found 
similar rates of PE in South Asian and non-Hispanic white Americans36. However, few previous studies have 
examined ethnic differences in BP trajectories across pregnancy38. A recent study compared Norweigian women 
with women from eastern Europe, middle east, Africa and south and east Asia, however only 200 south Asian 
women were included and BP was recorded just twice antenatally39.
Hypertensive disorder
Mean difference in average SBP change, mm Hg/wk
Mean Difference in 
SBP at 8 wk, mmHg 8–24 weeks 24–30 weeks 30–36 weeks ≥36 weeks
No hypertensive disorder
White British women 0 0 0 0 0
Pakistani women −4.00 (−4.71 to −3.29) 0.02 (−0.04 to 0.08) −0.15 (−0.27 to −0.03) 0.09 (−0.02 to 0.21) 0.01 (−0.19 to 0.20)
Gestational hypertension
White British women 0 0 0 0 0
Pakistani women −4.93 (−7.74 to −2.12) 0.15 (−0.09 to 0.38) −0.40 (−0.91 to 0.11) −0.15 (−0.37 to 0.67) 0.89 (0.03 to 1.74)
Pre-eclampsia
White British women 0 0 0 0 0
Pakistani women −2.58 (−7.16 to 2.00) −0.11 (−0.50 to 0.27) 0.84 (0.59 to 1.62) 0.32 (−0.63 to 1.27) −0.06 (−1.89 to 1.77)
Table 4. Mean difference (95% CI) in SBP at 8 weeks and change in SBP in each period of gestation for each 
hypertensive disorders of pregnancy. Adjusted model adjusted for time to delivery and for maternal age, 
pregnancy booking BMI, parity, smoking in pregnancy status, education, gestational diabetes and infant gender. 
In reference category: No hypertensive disorder (white British women) mean SBP at 8 wk (mm Hg) 105.84 
(104.32 to 107.37); mean SBP change (mm Hg/wk): 8–24 wk 0.15 (0.03 to 0.28); 24–30 wk 0.20 (−0.05 to 0.45); 
30–36 wk 0.13 (−0.12 to 0.38); >36 wk 1.33 (0.93 to 1.73). In reference category: gestational hypertension 
(white British women), mean SBP at 8 wk (mm Hg) 108.59 (102.95 to 114.23); mean SBP change (mm Hg/
wk): 8–24 wk 0.29 (−0.18 to 0.76); 24–30 wk 0.57 (−0.43 to 1.56); 30–36 wk 0.47 (−0.54 to 1.48); >36 wk 3.25 
(1.74 to 4.76). In reference category: pre-eclampsia (white British women), mean SBP at 8 wk (mm Hg) 112.27 
(102.17 to 122.37); mean SBP change (mm Hg/wk): 8–24 wk 0.09 (−0.83 to 1.00); 24–30 wk 0.47. (−1.31 to 
2.24); 30–36 wk 1.58 (−0.16 to 3.32); >36 wk 1.13 (−2.25 to 4.52).
Hypertensive disorder
Mean difference in average DBP change, mmHg/wk
Mean Difference in 
SBP at 8 wk, mmHg 8–24 weeks 24–30 weeks 30–36 weeks ≥36 weeks
No hypertensive disorder
White British women 0 0 0 0 0
Pakistani women −1.92 (−2.44 to −1.40) 0.04 (0.01 to 0.08) −0.06 (−0.14 to 0.03) −0.10 (−0.19 to 0.01) 0.19 (0.04 to 0.34)
Gestational hypertension
White British women 0 0 0 0 0
Pakistani women −1.58 (−3.60 to 0.44) 0.12 (−0.05 to 0.29) −0.21 (−0.59 to 0.16) −0.04 (−0.35 to 0.43) 0.29 (−0.34 to 0.93)
Pre-eclampsia
White British women 0 0 0 0 0
Pakistani women 0.48 (−2.93 to 3.88) −0.16 (−0.45 to 0.13) 0.86 (0.28 to 1.45) −0.32 (−0.98 to 0.34) 0.77 (0.41 to 1.96)
Table 5. Mean difference (95% CI) in DBP at 8 weeks and change in DBP in each period of gestation for each 
hypertensive disorders of pregnancy. Adjusted model adjusted for time to delivery and for maternal pregnancy 
booking BMI, age, parity, smoking in pregnancy status, education, gestational diabetes and infant gender. In 
reference category: No hypertensive disorder (white British women) mean DBP at 8 wk (mm Hg) 62.31 (61.21 
to 63.40); mean DBP change (mm Hg/wk): 8–24 wk 0.02 (−0.08 to 0.11); 24–30 wk 0.25 (0.06 to 0.44); 30–36 
wk 0.34 (0.15 to 0.54); >36 wk 1.28 (0.96 to 1.59). In reference category: gestational hypertension (white 
British women), mean DBP at 8 wk (mm Hg) 64.84 (60.88 to 68.80); mean DBP change (mm Hg/wk): 8–24 wk 
0.02(−0.31 to 0.36); 24–30 wk 1.07 (0.35 to 1.79); 30–36 wk 0.15 (−0.59 to 0.89); >36 wk 3.04 (1.93 to 4.15). In 
reference category: pre-eclampsia (white British women), mean DBP at 8 wk (mm Hg) 69.38 (61.89 to 76.89); 
mean DBP change (mm Hg/wk): 8–24 wk −0.02 (−0.66 to 0.70); 24–30 wk −0.12. (−1.44 to 1.20); 30–36 wk 
1.90 (0.56 to 3.25); >36 wk 2.68 (0.13 to 5.24).
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The lower rate of GH in Pakistani compared with white British women in our study is not surprising given the 
lower SBP and DBP of Pakistani women at the start of pregnancy and between 20 and 36 weeks gestation, and that 
criteria for the diagnosis of HDP are the same in both ethnic groups22.
Our findings provide some evidence for considering the rate of change or trajectory patterns of gestational BP, 
particularly for understanding ethnic differences in rates of HDP. The use of BP change across pregnancy (usu-
ally an increase of >15 mmHg or more from baseline reading) to identify women at increased risk of an adverse 
outcome has been explored for over 30 years48. However inconsistencies in study methods and their reported 
findings, together with the complexity of incorporating such measures into clinical guidelines and practice has so 
far prevented its adoption49,50.
We did not show a decline in BP from early pregnancy to 18/20 weeks that previous studies found18,38,51. This is 
unlikely to reflect a lack of measurements at 18 to 24 weeks because antenatal measurements were obtained at regu-
lar intervals across pregnancy and this did not change over the period of the study22,41. The transitory decline in BP 
in early pregnancy is thought to reflect the early haemodynamic changes of pregnancy and its end point (around 
20 weeks) is used as the marker after which GH and PE are diagnosed. Our finding of a gradual increase in BP in 
the first two trimesters of pregnancy for normotensive women and women with GH and PE (with the exception of 
white British women with PE, who showed a decline from 24 to 30 weeks), in both ethnic groups, may reflect the 
changing characteristics of pregnant women over time and the greater prevalence of risk factors for HDP19. For 
example, the proportion of women who were overweight and obese included in our previous UK cohort which 
recruited women in pregnancy in 1990 were 15% and 6%, respectively18,52; in this study, which recruited women 20 
years later and from an area of the UK with more deprivation, 29% were overweight and 22% obese40.
Our study is large with many repeated measurements, which allowed a consistent approach to the classifi-
cation of GH and PE. Use of routinely collected data will introduce a degree of variability, for example use of 
different BP measurement devices or use of different sized arm cuffs, however all measurements were collected in 
accordance with clinical care at the time of recruitment and accurately reflect the measurements used to inform 
clinical decisions related to the diagnosis and treatment of HDP in our study population.
The most recent International Society for the Study of Hypertension in pregnancy (ISSHP) guidance defines 
PE as high BP on at least two occasions after 20 weeks with concurrent significant proteinuria defined as 2+ on 
a reagent strip21, the UK NICE do not comment on how many + are appropriate22. Our use of 1+ proteinuria on 
reagent strip in defining PE reflects the ISSHP criteria for diagnosing PE and what was used in clinical practice in 
the UK at the time of our study (which preceded the most recent ISSHP guidelines)53.
Compared with the most recent ISSHP criteria our use of 1+ proteinuria may have increased the overall 
prevalence of PE in our study. However, this will not have altered the ethnic differences in BP trajectories nor the 
similarity in PE between white British and Pakistani women, which was driven by the steepear increase in BP in 
Pakistani women. Some of the weaker associations of risk factors with PE compared with GH shown in Table 3 
may be because of a lower proteinuria threshold, but given the relatively small numbers with PE and imprecise 
estimates with wide confidence intervals, we would not be able to distinguish differences in associations with a 
stricter definition of proteinuria, as the number with PE would be smaller.
Other measures of proteinuria, for example protein-creatinine ratio, may more accurately estimate protein-
uria, but they were not consistently recorded at each antenatal visit. Indicators of severe PE, such as evidence of 
multi-organ involvement were unavailable in our study, so we cannot assess severe PE or eclampsia.
In conclusion, BP trajectories differ by ethnicity. Pakistani women had lower BP at the start of pregnancy 
and during the first two trimesters, irrespective of the development of a HDP or the presence of a risk factor. 
Compared to white British women, Pakistani women who developed GH or PE showed steeper increases in BP 
Blood pressure variable
Length of gestation
White British women Pakistani women
% Increase in 
gestation 95% CI
% Increase in 
gestation 95% CI
SBP at 8 weeks, mmHg 0.00 0.00, 0.01 0.00 −0.01, 0.00
SBP change, mmHg/wk
8–24 wk −0.26 −0.74, −0.01 −0.07 −0.56, 0.28
24–30 wk 0.09 −1.80, 1.20 −0.02 −2.43, 1.14
30–36 wk −0.54 −32.55, 2.09 −0.09 −2.15, 1.04
≥36 wk −0.21 −1.18, 0.45 −0.09 −0.28, 0.03
DBP at 8 weeks, mmHg 0.00 0.01, 0.02 0.00 −0.01, 0.00
DBP change, mmHg/wk
8–24 wk −0.03 −4495.20, 2.27 −0.38 −2.96, 0.29
24–30 wk −0.19 −5.51, 1.51 −0.11 −4.51, 1.44
30–36 wk −0.42 −1.42, 0.32 −0.26 −1.36, 0.53
>36 wk −0.08 −0.77, 0.49 −0.04 −0.43, 0.30
Table 6. Associations of blood pressure at 8 weeks gestation and changes in blood pressure in each period of 
pregnancy with the time to delivery. Model 2 adjusted for HDP category and maternal covariates and for SBP/
DBP at 8 weeks’ gestation and SBP/DBP change in BP in earlier periods of pregnancy.
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towards the end of pregnancy. Because GH developed evenly between 20–36 weeks and after 36 weeks gestation 
and PE occurred more commonly after 36 weeks in both ethnic groups, lower BP up to the third trimester in 
Pakistani women resulted in a considerably lower GH rate, whereas PE rate, influence by the steep third trimester 
BP increase is similar in the two groups. Criteria for diagnosing HDP may benefit from considering ethnic differ-
ences in BP change across pregnancy.
Data Availability
The Born in Bradford Study allows bone fide researchers to access data. Full details of how to do this are provided 
on the study web pages (https://borninbradford.nhs.uk/research/how-to-access-data/).
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